High expression of DEK is associated with poor prognosis in hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Soo Yeon | - |
dc.contributor.author | Jung, Wonkyung | - |
dc.contributor.author | Lee, Jinhwan | - |
dc.contributor.author | Kim, Aeree | - |
dc.contributor.author | Kim, Han Kyeom | - |
dc.contributor.author | Kim, Baek-Hui | - |
dc.date.accessioned | 2021-09-01T01:26:21Z | - |
dc.date.available | 2021-09-01T01:26:21Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 0213-3911 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62091 | - |
dc.description.abstract | DEK is an oncogene that has been identified as part of the DEK-CAN fusion gene. DEK plays a role in carcinogenesis through WNT signaling and induces cell proliferation through cyclin-dependent kinase signaling. DEK overexpression has been reported in HCC, but the clinical significance is unclear. This study enrolled 221 cases of HCC. The expression of DEK protein was evaluated by immunohistochemical staining. Cdk4, cyclin D1, Wnt10b, E-cadherin, and beta-catenin were also immunohistochemically stained and analyzed for correlation. The association of clinicopathologic factors with DEK expression was analyzed. DEK expression was observed in 44.8% (99/221) of cases. DEK expression showed a statistical association with clinicopathologic factors, including Edmondson-Steiner grade, presence of vascular emboli, and multiplicity (p<0.05). Among the other IHC markers, the expression of cdk4 was correlated with DEK expression (p<0.05). Patients with high DEK expression showed a significantly lower overall survival rate (p=0.006). However, the disease-free survival rate did not differ significantly. In addition, in a Cox regression model analysis, DEK expression was an independent prognostic factor. In summary, high expression of DEK was observed in HCC and was associated with poor prognostic marker expression and poor prognosis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | F HERNANDEZ | - |
dc.title | High expression of DEK is associated with poor prognosis in hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Han Kyeom | - |
dc.contributor.affiliatedAuthor | Kim, Baek-Hui | - |
dc.identifier.doi | 10.14670/HH-18-125 | - |
dc.identifier.scopusid | 2-s2.0-85074506885 | - |
dc.identifier.wosid | 000494654500008 | - |
dc.identifier.bibliographicCitation | HISTOLOGY AND HISTOPATHOLOGY, v.34, no.11, pp.1279 - 1288 | - |
dc.relation.isPartOf | HISTOLOGY AND HISTOPATHOLOGY | - |
dc.citation.title | HISTOLOGY AND HISTOPATHOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1279 | - |
dc.citation.endPage | 1288 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | DEK | - |
dc.subject.keywordAuthor | Prognostic marker | - |
dc.subject.keywordAuthor | Immunohistochemistry | - |
dc.subject.keywordAuthor | Pathology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.